Clinical practice guidelines for the management of adult diffuse gliomas

To follow the revision of the fourth edition of WHO classification and the recent progress on the management of diffuse gliomas, the joint guideline committee of Chinese Glioma Cooperative Group (CGCG), Society for Neuro‐Oncology of China (SNO-China) and Chinese Brain Cancer Association (CBCA) updat...

Full description

Saved in:
Bibliographic Details
Published in:Cancer letters Vol. 499; pp. 60 - 72
Main Authors: Jiang, Tao, Nam, Do-Hyun, Ram, Zvi, Poon, Wai-sang, Wang, Jiguang, Boldbaatar, Damdindorj, Mao, Ying, Ma, Wenbin, Mao, Qing, You, Yongping, Jiang, Chuanlu, Yang, Xuejun, Kang, Chunsheng, Qiu, Xiaoguang, Li, Wenbin, Li, Shaowu, Chen, Ling, Li, Xuejun, Liu, Zhixiong, Wang, Weimin, Bai, Hongmin, Yao, Yu, Li, Shouwei, Wu, Anhua, Sai, Ke, Li, Guilin, Yao, Kun, Wei, Xinting, Liu, Xianzhi, Zhang, Zhiwen, Dai, Yiwu, Lv, Shengqing, Wang, Liang, Lin, Zhixiong, Dong, Jun, Xu, Guozheng, Ma, Xiaodong, Zhang, Wei, Zhang, Chuanbao, Chen, Baoshi, You, Gan, Wang, Yongzhi, Wang, Yinyan, Bao, Zhaoshi, Yang, Pei, Fan, Xing, Liu, Xing, Zhao, Zheng, Wang, Zheng, Li, Yiming, Wang, Zhiliang, Li, Guanzhang, Fang, Shengyu, Li, Lianwang, Liu, Yanwei, Liu, Shuai, Shan, Xia, Liu, Yuqing, Chai, Ruichao, Hu, Huimin, Chen, Jing, Yan, Wei, Cai, Jinquan, Wang, Hongjun, Chen, Lingchao, Yang, Yuan, Wang, Yu, Han, Lei, Wang, Qixue
Format: Journal Article
Language:English
Published: Ireland Elsevier B.V 28.02.2021
Elsevier Limited
Subjects:
Adults
Brain cancer
Chemoradiation
Chemotherapy
Chromosomes
Classification
Clinical medicine
Clinical practice guidelines
Clinical trials
Diagnostic tests
Glioma
Histology
Immune therapy
Management
Medical prognosis
Molecular diagnostics
Mutation
Oncology
Patients
Pediatrics
Radiation therapy
Surgery
Target therapy
Tumors
China
Immune therapy
Molecular diagnostics
Surgery
Chemoradiation
Target therapy
ISSN:0304-3835, 1872-7980, 1872-7980
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To follow the revision of the fourth edition of WHO classification and the recent progress on the management of diffuse gliomas, the joint guideline committee of Chinese Glioma Cooperative Group (CGCG), Society for Neuro‐Oncology of China (SNO-China) and Chinese Brain Cancer Association (CBCA) updated the clinical practice guideline. It provides recommendations for diagnostic and management decisions, and for limiting unnecessary treatments and cost. The recommendations focus on molecular and pathological diagnostics, and the main treatment modalities of surgery, radiotherapy, and chemotherapy. In this guideline, we also integrated the results of some clinical trials of immune therapies and target therapies, which we think are ongoing future directions. The guideline should serve as an application for all professionals involved in the management of patients with adult diffuse glioma and also a source of knowledge for insurance companies and other institutions involved in the cost regulation of cancer care in China and other countries. •The guideline provides diagnostic and management recommendations for diffuse gliomas.•The guideline focuses on molecular diagnostics, and the main treatment modalities.•The guideline includes clinical trials of immune therapies and target therapies.•The guideline should serve as an application for all medical professionals.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Instructional Material/Guideline-3
content type line 23
ISSN:0304-3835
1872-7980
1872-7980
DOI:10.1016/j.canlet.2020.10.050